• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国肝细胞癌和肝内胆管癌发病率趋势的比较。

A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.

作者信息

McGlynn Katherine A, Tarone Robert E, El-Serag Hashem B

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Department of Health and Human Services, EPS-7060, 6120 Executive Boulevard, Rockville, MD 20854-7234, USA.

出版信息

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1198-203. doi: 10.1158/1055-9965.EPI-05-0811.

DOI:10.1158/1055-9965.EPI-05-0811
PMID:16775181
Abstract

The incidence rates of liver cancers, both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), are increasing in the U.S. It is possible that the increases are related to common exposures, and if so, similar trends in incidence by gender, age, ethnicity, and calendar period, might exist. To examine this hypothesis, age-specific trends in the incidence of HCC and ICC in the Surveillance, Epidemiology and End Results program (1976-2000) were examined by year of diagnosis and year of birth. Age-period-cohort models were also fit to the data. The incidence of HCC in the most recent time period was twice as high among Black men (8.8/100,000) and women (2.6/100,000) as among White men (4.6/100,000) and women (1.2/100,000). However, between 1976 and 2000, incidence among all four ethnic- and gender-specific groups increased by >90% (White males, 123.2%; White females, 96.8%; Black males, 97.9%; Black females, 91.9%) with young White men experiencing the greatest increases (432%). In contrast, ICC rates were similar for Black (0.93/100,000) and White men (0.92/100,000), but higher for White (0.57/100,000) than Black women (0.39/100,000). Although ICC incidence increased among all groups, the increase was greatest for Black men (138.5%), followed by White men (124.4%), White women (111.1%), and Black women (85.7%) Age-period-cohort analyses of HCC revealed a significant cohort effect among younger men (45-65 years old), but not older men (65-84 years old), suggesting possible differences in etiology. In conclusion, the rates of HCC and ICC approximately doubled between 1976 and 2000. Trends by age, gender, ethnicity, and birth cohort suggest that heterogeneity exists in the factors influencing these rates.

摘要

在美国,肝癌(包括肝细胞癌和肝内胆管癌)的发病率正在上升。发病率的上升可能与常见暴露因素有关,如果是这样,按性别、年龄、种族和日历时间划分的发病率可能存在相似趋势。为检验这一假设,利用监测、流行病学和最终结果计划(1976 - 2000年)中按诊断年份和出生年份划分的肝细胞癌和肝内胆管癌发病率的年龄特异性趋势进行了研究。年龄 - 时期 - 队列模型也适用于这些数据。在最近时间段内,黑人男性(8.8/10万)和女性(2.6/10万)的肝细胞癌发病率是白人男性(4.6/10万)和女性(1.2/10万)的两倍。然而,在1976年至2000年期间,所有四个种族和性别特定组的发病率均增加了90%以上(白人男性,123.2%;白人女性,96.8%;黑人男性,97.9%;黑人女性,91.9%),年轻白人男性的发病率增幅最大(432%)。相比之下,黑人男性(0.93/10万)和白人男性(0.92/10万)的肝内胆管癌发病率相似,但白人女性(0.57/10万)的发病率高于黑人女性(0.39/10万)。尽管所有组的肝内胆管癌发病率都有所上升,但黑人男性的增幅最大(138.5%),其次是白人男性(124.4%)、白人女性(111.1%)和黑人女性(85.7%)。肝细胞癌的年龄 - 时期 - 队列分析显示,年轻男性(45 - 65岁)存在显著的队列效应,而老年男性(65 - 84岁)则没有,这表明病因可能存在差异。总之,1976年至2000年期间,肝细胞癌和肝内胆管癌的发病率大约翻了一番。按年龄、性别、种族和出生队列划分的趋势表明,影响这些发病率的因素存在异质性。

相似文献

1
A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.美国肝细胞癌和肝内胆管癌发病率趋势的比较。
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1198-203. doi: 10.1158/1055-9965.EPI-05-0811.
2
Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.美国肝内胆管细胞癌与肝细胞癌的临床特征和结局比较。
Hepatology. 2021 Nov;74(5):2622-2632. doi: 10.1002/hep.32007. Epub 2021 Sep 25.
3
Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.美国肝内胆管癌、肝外胆管癌和肝细胞癌的地理差异。
PLoS One. 2015 Apr 2;10(3):e0120574. doi: 10.1371/journal.pone.0120574. eCollection 2015.
4
Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA.美国肝细胞癌发病率中种族和性别特异性趋势的队列贡献
World J Surg. 2018 Mar;42(3):835-840. doi: 10.1007/s00268-017-4194-1.
5
[Increased incidence of hepatocellular and intrahepatic cholangiocellular carcinoma in northeast Germany].[德国东北部肝细胞癌和肝内胆管细胞癌发病率上升]
Dtsch Med Wochenschr. 2006 Jul 28;131(30):1649-55. doi: 10.1055/s-2006-947811.
6
Do the existing staging systems for primary liver cancer apply to combined hepatocellular carcinoma-intrahepatic cholangiocarcinoma?现有的原发性肝癌分期系统是否适用于肝细胞癌-肝内胆管癌?
Hepatobiliary Pancreat Dis Int. 2021 Feb;20(1):13-20. doi: 10.1016/j.hbpd.2020.10.002. Epub 2020 Oct 27.
7
Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.肝细胞-胆管细胞癌:一种罕见原发性肝癌的人群水平分析
Liver Transpl. 2014 Aug;20(8):952-9. doi: 10.1002/lt.23897. Epub 2014 Jul 3.
8
Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project.按性别划分的咖啡摄入量与肝细胞癌和肝内胆管癌风险:肝癌合并项目
Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1398-406. doi: 10.1158/1055-9965.EPI-15-0137. Epub 2015 Jun 30.
9
Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors.肝细胞癌合并胆管癌:人口统计学、临床及预后因素
Cancer. 2002 Apr 1;94(7):2040-6. doi: 10.1002/cncr.10392.
10
Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study.肝移植患者中的肝内胆管细胞癌或混合性肝细胞-胆管细胞癌:一项西班牙匹配队列多中心研究。
Ann Surg. 2014 May;259(5):944-52. doi: 10.1097/SLA.0000000000000494.

引用本文的文献

1
High cellular prion protein expression in cholangiocarcinoma: A marker for early postoperative recurrence and unfavorable prognosis.胆管癌中细胞朊蛋白高表达:早期术后复发及不良预后的标志物
World J Gastrointest Surg. 2025 Mar 27;17(3):101940. doi: 10.4240/wjgs.v17.i3.101940.
2
Survival Benefit of Surgical Treatment for Elderly Patients with Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study in the SEER Database by Propensity Score Matching Analysis.手术治疗老年肝内胆管细胞癌患者的生存获益:SEER 数据库倾向评分匹配分析的回顾性队列研究。
Curr Oncol. 2023 Feb 22;30(3):2642-2652. doi: 10.3390/curroncol30030201.
3
Molecular Pathogenesis and Regulation of the -Family: Involvement of and in Intra-Hepatic Cholangiocarcinoma.
-家族的分子发病机制与调控:α和β在肝内胆管癌中的作用
Cancers (Basel). 2021 Jun 4;13(11):2804. doi: 10.3390/cancers13112804.
4
MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients.MRPL27 与胆管癌患者的总生存和无病生存不良相关。
Int J Med Sci. 2021 Jan 1;18(4):936-943. doi: 10.7150/ijms.50782. eCollection 2021.
5
AGO1 enhances the proliferation and invasion of cholangiocarcinoma via the EMT-associated TGF-β signaling pathway.AGO1通过与上皮-间质转化相关的TGF-β信号通路增强胆管癌的增殖和侵袭。
Am J Transl Res. 2020 Jun 15;12(6):2890-2902. eCollection 2020.
6
MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.MRI 特征可预测肝内胆管细胞癌中的微血管侵犯。
Cancer Imaging. 2020 Jun 23;20(1):40. doi: 10.1186/s40644-020-00318-x.
7
Distinct clinical and prognostic implication of IDH1/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma.IDH1/2 突变和其他常见突变在大导管型和小导管型肝内胆管细胞癌中的不同临床和预后意义。
BMC Cancer. 2020 Apr 15;20(1):318. doi: 10.1186/s12885-020-06804-6.
8
An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.一种算法免疫组化方法来定义肿瘤类型并确定起源部位。
Adv Anat Pathol. 2020 May;27(3):114-163. doi: 10.1097/PAP.0000000000000256.
9
Neuroendocrine Changes in Cholangiocarcinoma Growth.神经内分泌变化在胆管癌生长中的作用。
Cells. 2020 Feb 13;9(2):436. doi: 10.3390/cells9020436.
10
Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy.肝内胆管细胞癌根治性切除术后的失败模式:对术后放疗的可能影响。
BMC Cancer. 2019 Nov 14;19(1):1108. doi: 10.1186/s12885-019-6328-3.